VC firm
Apple Tree Partners
Also known as Apple Tree Venture Management
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Founded
- 1999
- Assets under management
- $3.6BForm ADV private fund GAV, as of 2026-04-07Source (opens in a new tab)
- Funds
- 1
- Legal name
- Apple Tree Partners
Claim, correct or request removal
Record updated 29 September 2026
About
Apple Tree Partners (ATP). a pioneer in life sciences venture capital, is developing the next generation of transformative biotechnology companies.
Investment approach
- Thesis
- The core of our strategy is to provide flexible capital and access to a world-class team, to build sustainable, research-driven enterprises that improve human lives.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Seth currently serves on the boards of Akero Therapeutics and Stoke Therapeutics as well as the boards of all portfolio companies created within ATP’s current fund to date.
- Investing status notes
- ATP and its portfolio companies continue to operate as usual.
Funds
- ATP LIFE SCIENCE VENTURES, L.P.
- Main fund
SEC registration
- Registered adviser
- APPLE TREE VENTURE MANAGEMENT LLC
- CRD number
- 163705 (opens in a new tab)
- SEC file number
- 802-75719
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $3.6Bas of 2026-04-07
- Private funds reported
- 1
- Principal office
- NEW YORK, NY, United States
Loading relationship preview